MétaCan
Menu
Back to cohort
Record W2018803305 · doi:10.1158/1538-7445.am2011-5464

Abstract 5464: Determination of total and encapsulated drug pharmacokinetics for CPX-351, a nanoscale liposomal fixed molar ratio of cytarabine-daunorubicin (Cyt:Daun)

2011· article· en· W2018803305 on OpenAlexaff
Travis Ciofani, Troy O. Harasym, Michael C.Y. Juan, Lawrence D. Mayer, Donna Cabral-Lilly, Sherwin Xie

Bibliographic record

VenueCancer Research · 2011
Typearticle
Languageen
FieldMaterials Science
TopicNanoparticle-Based Drug Delivery
Canadian institutionsCelator Pharmaceuticals (Canada)
Fundersnot available
KeywordsPharmacokineticsDaunorubicinChemistryChromatographyLiposomeDrugPharmacologyHigh-performance liquid chromatographyAnalyteCytarabineMedicineLeukemiaBiochemistryImmunology

Abstract

fetched live from OpenAlex

Abstract Background: CPX-351 is a liposomal formulation that delivers elevated concentrations of Cyt and Daun after administration in vivo and maintains the two drugs at a 5:1 molar ratio shown to be synergistic in preclinical studies. Pharmacokinetic analysis of CPX-351 in advanced leukemia patients demonstrated prolonged plasma exposure of the drugs with quantifiable concentrations of both agents being observed as long as 7 days after the final CPX-351 dose. Here we developed a method to separate liposome-bound from unencapsulated drugs, thereby allowing the pharmacokinetics of encapsulated agents to be determined in comparison to total plasma drug concentrations. Methods: CPX-351 was administered to female Sprague-Dawley rats via IV bolus injection. Plasma samples were harvested at five timepoints from 1 – 24 hours. Unencapsulated drug analysis was conducted by addition of internal standards (gemcitabine (Cyt) and doxorubicin (Daun)) to the plasma, followed by a 5-fold dilution in buffer and ultrafiltration using Microcon YM-30. Unencapsulated drug levels were determined by reversed-phase HPLC-MS (SIM, 244.2 m/z (Cyt) and 528.3 m/z (Daun)). Total analysis was conducted by protein precipitation and analysis was determined by reversed-phase HPLC-UV (Cyt) and reversed-phase HPLC-Fluorescence (Daun). Results: A separation method was developed to separate 0.22 – 4.33% unencapsulated Cyt and 0.13 – 2.50% unencapsulated Daun from liposome in plasma matrix. Encapsulated drug was calculated by subtracting the amount of unencapsulated analyte from the corresponding amount of total analyte. The total drug curves and the calculated encapsulated drug curves from 1 – 24 hours were superimposable for Cyt and Daun. A maximum of 1.9% unencapsulated Cyt and 0.4% unencapsulated Daun was measured in the plasma at any time point. Conclusions: Unencapsulated drug levels in rat plasma are insignificant compared to the total drug levels such that levels of total and encapsulated are within the spread of the data and therefore indistinguishable. These results suggest that CPX-351 remains in circulation in rats as intact liposomes at least 24 hours post administration. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 5464. doi:10.1158/1538-7445.AM2011-5464

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.003

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.061
GPT teacher head0.348
Teacher spread0.287 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2011
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicNanoparticle-Based Drug DeliveryFrench-language works237,207